<DOC>
	<DOCNO>NCT01929421</DOCNO>
	<brief_summary>To assess efficacy safety salvage tratment Gemcitabine S-1 Combination metastatic colorectal cancer</brief_summary>
	<brief_title>A Phase II Trial Salvage Treatment With Gemcitabine S-1 Combination Patients With Heavily Treated Advanced Colorectal Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>non resectable colorectal adenocarcinoma . disease progression within 6months treatment irinotecan oxaliplatin contaning regimen . estimate life expectancy 3 month . ECOG status 2 low tumor type adenoarcinoma . presence history CNS metastasis . evidence gastrointestinal bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>S-1</keyword>
</DOC>